Fact CheckerSign in

NCT06834880Completed

AQT90 FLEX NTproBNP2 Test Kit - 23004 - Reference Interval Study

AQT90 FLEX NTproBNP2 Test Kit - 23004 - Reference Interval Study Protocol

Source: ClinicalTrials.gov · Last updated 6 Aug 2025

Brief summary (registry, in English)

The purpose of this study is to establish the overall (age- and sex independent) at least 95th percentile upper reference limit (URL) of the NTproBNP2 Test Kit on the AQT90 FLEX analyzer.

Status (registry)
Completed
Study type
Observational
Enrollment
781 (actual)
First submitted
6 Feb 2025
Start date
27 Jan 2025
Primary completion date
5 Feb 2025
Lead sponsor
Radiometer Medical ApS
NCT number
NCT06834880

What you commit to

  • Study type: Observational
  • Participants enrolled: 781
  • From 27 Jan 2025 to the primary completion date, 5 Feb 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Answered yes to any of the conditions below (Information gathered from a self-reported health questionnaire or results from blood sample tests):
  • Current medications for treating cardiovascular diseases at the time of sample collection
  • Current antibiotics (Indicates ongoing infections)

Lab values

  • Known to suffer from any of the illnesses below at the time of sample collection:
    • Disease(s) of/or affecting the cardiovascular system
    • Congestive heart failure
    • Hypertension
    • Previous history of any heart disease
    • Diabetes (Either self-reported in questionnaire or a glycosylated hemoglobin (HbA1C) in the diabetic range (above 6.4%)
    • Renal dysfunction or failure (An estimated glomerular filtration rate (eGFR) below 60 mL/min/1.73m2.) This is to be calculated using information on age, sex and creatinine using the 2021 chronic kidney disease epidemiology (CKD-EPI) creatinine equation.
    • Cancer or history of cancer

Who the study is looking for

  • Subject must have given their valid consent to donate their sample in the sample bank
  • Subjects must have been 18 years of age or older at the time of sample collection
  • Subject must have answered yes, to being generally healthy, in the health questionnaire
  • Subjects must, as a minimum, have completed questions regarding age, gender, race, and ethnicity

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Radiometer Turku Oy
Coordinator of this site? Confirm its status
TurkuFinlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.